Target intelligence / Profile preview

ETS-related gene response element (ERG-RE)

Target
ERG-RE
Molecular classification
Nucleic acid, Transcription factor binding site, DNA motif
01

Overview

The ETS-related gene (ERG) response element consists of specific double-stranded DNA sequences, typically containing a conserved 5'-GGAA/T-3' core motif, that serve as the primary docking sites for the ERG transcription factor (Sizemore et al., 2017). In healthy physiological states, ERG binds to these motifs to regulate genes essential for vascular development, angiogenesis, and hematopoiesis. However, in approximately 50% of prostate cancer cases, a chromosomal translocation creates the TMPRSS2-ERG fusion, resulting in the massive overexpression of ERG (Tomlins et al., 2005). This leads to the aberrant activation of oncogenic pathways as ERG binds to its response elements to drive cell invasion and epithelial-mesenchymal transition. Because transcription factors are traditionally difficult to target with small molecules, therapeutic strategies have shifted toward the DNA motif itself. These include the use of decoy oligonucleotides that mimic the response element to sequester ERG protein and small molecules like DB1255 that bind the DNA minor groove at these specific sites to competitively inhibit ERG recruitment (Nhili et al., 2013).

Other names
ERG binding siteETS binding siteERG-binding DNA motifERG-responsive elementEBS
02

Mechanism of action

Competitive inhibition of transcription factor binding via DNA minor groove binding or decoy sequestration.

03

Biological functions

Transcription regulationCell proliferationAngiogenesisCell migrationHematopoiesisEpithelial-mesenchymal transition
04

Disease associations

Prostate cancerAcute myeloid leukemiaEwing sarcomaVascular disorders
05

Safety considerations

Off-target binding to other ETS family response elementsSystemic toxicity of DNA-binding small moleculesChallenges in the delivery and stability of oligonucleotide decoysPotential disruption of normal hematopoiesis and vascular function
06

Interacting drugs

DB1255

3 more in the full profile.

07

Biomarkers

TMPRSS2-ERG gene fusionERG protein overexpressionERG mRNA levels

Beyond the preview

Go deeper on ETS-related gene response element (ERG-RE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ETS-related gene response element (ERG-RE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call